Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. (Q54454112)

30 May 2018

title

Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. (English)

1 reference

30 May 2018

0 references

5

Helge Karch

1 reference

30 May 2018

Martina Bielaszewska

1

object named as

Martina Bielaszewska

1 reference

30 May 2018

Alex Friedrich

2

object named as

Alexander W Friedrich

1 reference

30 May 2018

Thomas Aldick

3

object named as

Thomas Aldick

1 reference

30 May 2018

author name string

Robin Schürk-Bulgrin

4

1 reference

30 May 2018

language of work or name

English

0 references

publication date

2 October 2006

1 reference

30 May 2018

Clinical Infectious Diseases

published in

1 reference

30 May 2018

volume

43

1 reference

30 May 2018

issue

9

1 reference

30 May 2018

page(s)

1160-1167

1 reference

30 May 2018

Shiga toxin-producing Escherichia coli infection

cites work

1 reference

Enterohaemorrhagic Escherichia coli in human medicine

21 January 2018

1 reference

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

21 January 2018

1 reference

Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome

21 January 2018

1 reference

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

21 January 2018

1 reference

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

21 January 2018

1 reference

The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings

21 January 2018

1 reference

Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.

21 January 2018

1 reference

Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

21 January 2018

1 reference

Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates

21 January 2018

1 reference

Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany

21 January 2018

1 reference

Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans

21 January 2018

1 reference

A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli.

21 January 2018

1 reference

Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles

21 January 2018

1 reference

Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells

21 January 2018

1 reference

A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.

21 January 2018

1 reference

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms

21 January 2018

1 reference

Phylogeny, clinical associations, and diagnostic utility of the pilin subunit gene (sfpA) of sorbitol-fermenting, enterohemorrhagic Escherichia coli O157:H-

21 January 2018

1 reference

Subtyping of pathogenic Escherichia coli strains using flagellar (H)-antigens: serotyping versus fliC polymorphisms.

21 January 2018

1 reference

The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model

21 January 2018

1 reference

Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome

21 January 2018

1 reference

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

21 January 2018

1 reference

Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen

21 January 2018

1 reference

Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period

21 January 2018

1 reference

Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents

21 January 2018

1 reference

Diversity of virulence patterns among shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics.

21 January 2018

1 reference

Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli

21 January 2018

1 reference

A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.

21 January 2018

1 reference

Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/508195

1 reference

30 May 2018

1 reference

30 May 2018